8-K 1 form8-kx10x13x21.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 13, 2021

INUVO, INC.
(Exact name of registrant as specified in its charter)

Nevada | 001-32442 | 87-0450450
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.)

500 President Clinton Ave., Ste. 300, Little Rock, AR | 72201
(Address of principal executive offices) | (Zip Code)

Registrant's telephone number, including area code | (501) 205-8508

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, $0.001 par value | INUV | NYSE MKT

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On October 13, 2021, Inuvo, Inc. issued a press release regarding preliminary financial performance for Q3 2021. A copy of the preliminary earnings release is being furnished herewith as Exhibit 99.1.
The information in this Current Report on Form 8-K under this caption and accompanying exhibit is being furnished under Item 2.02 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 (the “Securities Act”) or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 7.01 REGULATION FD DISCLOSURE.
On October 13, 2021, Inuvo, Inc. released an updated investor relations presentation.
A copy of the updated presentation is attached as Exhibit 99.2, and is incorporated by reference into this Current Report on Form 8-K.
The information in this Current Report on Form 8-K under this caption and accompanying exhibit is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits.
Exhibit No. Description
99.1 Press Release for preliminary Q3 2021 financial results.
99.2 Investor Relations Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| INUVO, INC.
Date: October 13, 2021 | By: | /s/ John Pisaris |
| John Pisaris, General Counsel

EXHIBIT INDEX

99.1 Press Release for preliminary Q3 2021 financial res ults.
99.2 Investor Relations Presentation